Tim Muilwijk

KU Leuven, GZA Ziekenhuizen Campus Sint-Augustinus

Papers

2

Total Citations

17

H-Index

2

About

Tim Muilwijk is a urological surgeon and researcher whose work focuses on advancing surgical techniques for prostate cancer, particularly through the use of robotic-assisted technologies. His major contributions center on improving oncological outcomes and refining surgical approaches for recurrent and localized prostate cancer. In his highly cited 2019 study, Muilwijk compared robot-assisted versus open salvage lymph node dissection for recurrent prostate cancer, demonstrating that the robotic approach offers comparable peri-operative and early oncological outcomes while potentially reducing surgical morbidity—a critical finding for patients seeking to delay palliative androgen deprivation therapy. This work has garnered 13 citations, underscoring its clinical relevance. Earlier, in 2017, he conducted a retrospective study on robot-assisted laparoscopic radical prostatectomy, analyzing discrepancies between pre- and post-operative Gleason scores to improve prognostic accuracy. Through these investigations, Muilwijk has helped bridge the gap between traditional open surgery and minimally invasive techniques, offering evidence that supports the adoption of robotic platforms in complex salvage settings. His research continues to shape best practices in urologic oncology, providing surgeons with data-driven insights to optimize patient care.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
13 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: KU Leuven, GZA Ziekenhuizen Campus Sint-Augustinus

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago